Renal News
  September 2008 << Return to the full newsletter  

Trust fund dollars support program improvements

Starting in the next issue of Renal News, we’ll highlight projects and purchases made possible through trust fund dollars from provincial contracts negotiated by the Renal Agency. Referred to as "value added funds" and provided through Baxter, Ortho Biotech and Amgen, these dollars support a range of staff and patient education projects, research initiatives, and data management/analysis tasks, as well as enabling the purchase of state-of-the-art equipment.

While a portion of the funds sponsor provincial initiatives, the majority is allocated to health authorities to meet local needs. A range of unique and innovative programs have been funded over the past few years, including medication reconciliation, workflow redesign and telehealth applications. The Baxter fund, focused on peritoneal dialysis, has sponsored the development of teaching materials at both the provincial level – for instance the PD training DVD – and within health authorities.

Stay tuned for details on these and other value-added projects. If you have a project you’d like us to feature, please email us at bcpra@bcpra.ca

<< Return to the full newsletter

Subscribe  |  Forward  |  Feedback  |  Privacy

www.bcrenalagency.ca

Copyright ©2007 BC Provincial Renal Agency. An Agency of the Provincial
Health Services Authority. All rights reserved.

PHSA improves the health of British Columbians by seeking province-wide solutions to specialized health care needs in collaboration with BC health authorities and other partners. For more information, visit www.phsa.ca